These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8481613)

  • 41. Cognitive executive function in Down's syndrome.
    Rowe J; Lavender A; Turk V
    Br J Clin Psychol; 2006 Mar; 45(Pt 1):5-17. PubMed ID: 16480563
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neurological complications in Down's Syndrome].
    Lev N; Melamed E
    Harefuah; 2002 Sep; 141(9):820-3, 857. PubMed ID: 12362489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive deficits and associated neurological complications in individuals with Down's syndrome.
    Lott IT; Dierssen M
    Lancet Neurol; 2010 Jun; 9(6):623-33. PubMed ID: 20494326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Various features of the paroxysaml manifestations of Down's disease (clinico-statistical analysis)].
    Fedomov DD; Shapiro IuL; Vaĭndrukh FA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(10):1516-21. PubMed ID: 4236970
    [No Abstract]   [Full Text] [Related]  

  • 45. Differential rates of psychiatric disorders in adults with Down's syndrome compared with other mentally handicapped adults.
    Collacott RA; Cooper SA; McGrother C
    Br J Psychiatry; 1992 Nov; 161():671-4. PubMed ID: 1422617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Down syndrome, Alzheimer's disease and seizures.
    Menéndez M
    Brain Dev; 2005 Jun; 27(4):246-52. PubMed ID: 15862185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphocyte concanavalin A capping: a similarity between Down's syndrome and early onset primary degenerative dementia.
    Duijndam-van den Berge M; Goekoop JG
    J Neurol Neurosurg Psychiatry; 1986 May; 49(5):595-8. PubMed ID: 2940340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.
    Krasuski JS; Alexander GE; Horwitz B; Rapoport SI; Schapiro MB
    Am J Psychiatry; 2002 Jan; 159(1):74-81. PubMed ID: 11772693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of rating scales for the diagnosis of dementia in adults with Down's syndrome.
    Deb S; Braganza J
    J Intellect Disabil Res; 1999 Oct; 43 ( Pt 5)():400-7. PubMed ID: 10546964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Down's syndrome.
    Roizen NJ; Patterson D
    Lancet; 2003 Apr; 361(9365):1281-9. PubMed ID: 12699967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of electroencephalography to detect Alzheimer's disease in Down's syndrome.
    Visser FE; Kuilman M; Oosting J; Overweg J; van Wijk J; van Huffelen AC
    Acta Neurol Scand; 1996 Aug; 94(2):97-103. PubMed ID: 8891053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The link between Down's syndrome and Alzheimer's disease: 2.
    Soliman A; Hawkins D
    Br J Nurs; 1998 Jul 23-Aug 12; 7(14):847-50. PubMed ID: 9849146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The EEG and incidence of epilepsy in Down's syndrome.
    Tangye SR
    J Ment Defic Res; 1979 Mar; 23(1):17-24. PubMed ID: 158092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A four year prospective study of age-related cognitive change in adults with Down's syndrome.
    Oliver C; Crayton L; Holland A; Hall S; Bradbury J
    Psychol Med; 1998 Nov; 28(6):1365-77. PubMed ID: 9854278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adults with Down's syndrome: the prevalence of complications and health care in the community.
    Henderson A; Lynch SA; Wilkinson S; Hunter M
    Br J Gen Pract; 2007 Jan; 57(534):50-5. PubMed ID: 17244425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Copper, ceruloplasmin and superoxide dismutase (SOD1) in patients with Down's syndrome.
    Tórsdóttir G; Kristinsson J; Hreidarsson S; Snaedal J; Jóhannesson T
    Pharmacol Toxicol; 2001 Dec; 89(6):320-5. PubMed ID: 11903959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behaviour phenotype for Down's syndrome.
    Collacott RA; Cooper SA; Branford D; McGrother C
    Br J Psychiatry; 1998 Jan; 172():85-9. PubMed ID: 9534839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical evaluation of dementia in Down's syndrome: a preliminary report.
    Thase ME; Liss L; Smeltzer D; Maloon J
    J Ment Defic Res; 1982 Dec; 26 (Pt 4)():239-44. PubMed ID: 6221112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case of Down's syndrome with diffuse Lewy body disease and Alzheimer's disease.
    Bodhireddy S; Dickson DW; Mattiace L; Weidenheim KM
    Neurology; 1994 Jan; 44(1):159-61. PubMed ID: 8290054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
    Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A
    Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.